Zurich Cantonal Bank’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $28M | Sell |
51,700
-3,124
| -6% | -$1.76M | 0.05% | 276 |
|
|
2026
Q1 | $32.5M | Buy |
54,824
+2,812
| +5% | +$1.4M | 0.07% | 225 |
|
|
2025
Q4 | $25.3M | Buy |
52,012
+32,689
| +169% | +$15.2M | 0.05% | 273 |
|
|
2025
Q3 | $8.1M | Sell |
19,323
-17,500
| -48% | -$5.89M | 0.02% | 502 |
|
|
2025
Q2 | $10.6M | Sell |
36,823
-9,923
| -21% | -$2.97M | 0.03% | 452 |
|
|
2025
Q1 | $14.4M | Buy |
46,746
+14,282
| +44% | +$4.89M | 0.04% | 372 |
|
|
2024
Q4 | $11.5M | Buy |
32,464
+3,341
| +11% | +$1.23M | 0.03% | 410 |
|
|
2024
Q3 | $10.4M | Sell |
29,123
-4,820
| -14% | -$1.63M | 0.03% | 431 |
|
|
2024
Q2 | $10.8M | Buy |
33,943
+8,833
| +35% | +$2.34M | 0.04% | 394 |
|
|
2024
Q1 | $5.77M | Buy |
25,110
+3,948
| +19% | +$891K | 0.02% | 518 |
|
|
2023
Q4 | $4.65M | Buy |
21,162
+13,130
| +163% | +$3.03M | 0.02% | 553 |
|
|
2023
Q3 | $1.81M | Sell |
8,032
-19
| -0.2% | -$4.38K | 0.01% | 732 |
|
|
2023
Q2 | $1.78M | Buy |
8,051
+159
| +2% | +$35.2K | 0.01% | 735 |
|
|
2023
Q1 | $1.77M | Buy |
7,892
+1,172
| +17% | +$289K | 0.01% | 716 |
|
|
2022
Q4 | $1.87M | Buy |
6,720
+769
| +13% | +$194K | 0.01% | 686 |
|
|
2022
Q3 | $1.25M | Buy |
5,951
+212
| +4% | +$47.4K | 0.01% | 784 |
|
|
2022
Q2 | $1.35M | Sell |
5,739
-378
| -6% | -$76.8K | 0.01% | 763 |
|
|
2022
Q1 | $1.1M | Sell |
6,117
-731
| -11% | -$139K | 0.01% | 896 |
|
|
2021
Q4 | $1.48M | Buy |
6,848
+1,654
| +32% | +$325K | 0.01% | 838 |
|
|
2021
Q3 | $959K | Sell |
5,194
-694
| -12% | -$137K | 0.01% | 953 |
|
|
2021
Q2 | $1.06M | Buy |
5,888
+441
| +8% | +$84K | 0.01% | 885 |
|
|
2021
Q1 | $911K | Buy |
5,447
+6
| +0.1% | +$1K | 0.01% | 913 |
|
|
2020
Q4 | $826K | Buy |
5,441
+590
| +12% | +$77.4K | 0.01% | 1032 |
|
|
2020
Q3 | $490K | Hold |
4,851
| – | – | ﹤0.01% | 1106 |
|
|
2020
Q2 | $587K | Buy |
4,851
+1,218
| +34% | +$137K | 0.01% | 951 |
|
|
2020
Q1 | $344K | Buy |
3,633
+374
| +11% | +$35.5K | ﹤0.01% | 985 |
|
|
2019
Q4 | $287K | Buy |
3,259
+472
| +17% | +$41.5K | ﹤0.01% | 1142 |
|
|
2019
Q3 | $222K | Buy |
2,787
+570
| +26% | +$45.9K | ﹤0.01% | 1196 |
|
|
2019
Q2 | $173K | Sell |
2,217
-4,750
| -68% | -$444K | ﹤0.01% | 1301 |
|
|
2019
Q1 | $818K | Hold |
6,967
| – | – | 0.01% | 819 |
|
|
2018
Q4 | $759K | Hold |
6,967
| – | – | 0.01% | 803 |
|
|
2018
Q3 | $891K | Hold |
6,967
| – | – | 0.01% | 813 |
|
|
2018
Q2 | $788K | Hold |
6,967
| – | – | 0.01% | 826 |
|
|
2018
Q1 | $783K | Hold |
6,967
| – | – | 0.01% | 810 |
|
|
2017
Q4 | $1.03M | Sell |
6,967
-1,168
| -14% | -$148K | 0.01% | 780 |
|
|
2017
Q3 | $953K | Buy |
8,135
+1,168
| +17% | +$149K | 0.01% | 784 |
|
|
2017
Q2 | $904K | Sell |
6,967
-1,411
| -17% | -$176K | 0.01% | 798 |
|
|
2017
Q1 | $1.13M | Sell |
8,378
-4,608
| -35% | -$698K | 0.01% | 762 |
|
|
2016
Q4 | $1.86M | Hold |
12,986
| – | – | 0.02% | 641 |
|
|
2016
Q3 | $1.53M | Sell |
12,986
-831
| -6% | -$99.8K | 0.02% | 682 |
|
|
2016
Q2 | $1.46M | Sell |
13,817
-2,265
| -14% | -$253K | 0.02% | 616 |
|
|
2016
Q1 | $1.79M | Sell |
16,082
-19,617
| -55% | -$2.48M | 0.02% | 567 |
|
|
2015
Q4 | $5.59M | Buy |
35,699
+4,689
| +15% | +$683K | 0.07% | 282 |
|
|
2015
Q3 | $4.07M | Sell |
31,010
-1,582
| -5% | -$254K | 0.06% | 327 |
|
|
2015
Q2 | $5.67M | Buy |
32,592
+8,692
| +36% | +$1.56M | 0.08% | 254 |
|
|
2015
Q1 | $4.12M | Buy |
+23,900
| New | +$3.64M | 0.06% | 329 |
|
|
2014
Q3 | – | Sell |
-18,000
| Closed | -$1.59M | – | 991 |
|
|
2014
Q2 | $1.59M | Sell |
18,000
-7,000
| -28% | -$673K | 0.05% | 445 |
|
|
2014
Q1 | $2.35M | Buy |
25,000
+8,000
| +47% | +$818K | 0.07% | 314 |
|
|
2013
Q4 | $1.92M | Sell |
17,000
-13,000
| -43% | -$1.17M | 0.06% | 333 |
|
|
2013
Q3 | $2.37M | Buy |
30,000
+8,000
| +36% | +$585K | 0.08% | 271 |
|
|
2013
Q2 | $1.45M | Buy |
+22,000
| New | +$1.42M | 0.05% | 341 |
|
Other funds holding UTHR
ACA
JT
Zurich Cantonal Bank's UTHR Position: Q2 2026 in Review
Zurich Cantonal Bank reduced its United Therapeutics (UTHR) stake by 5.7% in Q2 2026, selling an estimated $1.76M and leaving 51,700 shares worth $28M. The position accounts for 0.05% of the portfolio, ranked #276.
Zurich Cantonal Bank first reported a position in UTHR in Q2 2013 and has held it in 51 quarters since. The position peaked at $32.5M in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Zurich Cantonal Bank held 51,700 shares of United Therapeutics worth $28M as of Q2 2026.
- Zurich Cantonal Bank sold 3,124 United Therapeutics shares in Q2 2026, an estimated $1.76M.
- United Therapeutics made up 0.05% of Zurich Cantonal Bank's portfolio in Q2 2026, its #276 holding.
- Zurich Cantonal Bank first reported a position in United Therapeutics in Q2 2013 and has held it in 51 quarters since.
- Zurich Cantonal Bank's United Therapeutics position peaked at $32.5M in Q1 2026.
- 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.